Have a personal or library account? Click to login
A quality of life assessment and the correlation between generic and disease-specific questionnaires scores in outpatients with chronic liver disease-pilot study Cover

A quality of life assessment and the correlation between generic and disease-specific questionnaires scores in outpatients with chronic liver disease-pilot study

Open Access
|Aug 2017

References

  1. 1. SINGH V., LUTHRA S., ELAJAMI TK., WELTY FK. Resolution of NASH with weight loss documented by hepatic MRI. BMJ Case Reports; 2015.10.1136/bcr-2014-207107
  2. 2. The World Health Organization quality of life assessment (WHOQOL): Position paper from the World Health Organization, Social Science & Medicine 1995; 41(10), 1403-1409.10.1016/0277-9536(95)00112-K
  3. 3. GARRAT A., SCHMIDT L., MACKINTOSH A., FITZPATRICK R. Quality of life measurment: bibliographic study of paient assessed health outcome measures. BMJ Case Reports 2002; 1417.10.1136/bmj.324.7351.1417
  4. 4. GOLDBERG DP., HILLIER VF. A scaled version of the General Health Questionnaire. Psychological Medicine 1979; 9(1):139-45.10.1017/S0033291700021644
  5. 5. SPRANGERS MAG., AARONSON NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review. Journal of Clinical Epidemiology 1992; 45(7):743-60.10.1016/0895-4356(92)90052-O
  6. 6. BAYLISS MS., GANDEK B., BUNGAY KM., DAVID S., HSU M-A., WARE JE. A Questionnaire to Assess the Generic and Disease-Specific Health Outcomes of Patients with Chronic Hepatitis C. Qual Life Res 1998; 7(1):39-55.
  7. 7. YOUNOSSI Z., GUYATT G., KIWI M., BOPARAI N., KING D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999; 45(2):295-300.10.1136/gut.45.2.295172760710403745
  8. 8. POPOVIC DD., KOVACEVIC NV., KISIC TEPAVCEVIC DB., TRAJKOVIC GZ., ALEMPIJEVIC TM., et al. Validation of the chronic liver disease questionnaire in Serbian patients. World J Gastroentero 2013; 19(30):4950-7.10.3748/wjg.v19.i30.4950374042523946600
  9. 9. MCCORMIC PM. Hepatic Cirrhosis, Sherlock’s Diseases of the liver and billiary system. In: DOOLEY SJ., LOK A., BURROUGHS KA., HEATHCOTE J., editors. Sherlock's Diseases of the Liver and Biliary System, 12th Edition; Wiley- Blackwell; 2011:103-20.
  10. 10. SARAVANAN P., CHAU WF., ROBERTS N., VEDHARA K., GREENWOOD R., DAYAN CM. Psychological well-being in patients on “adequate” doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrin 2002; 57:577-85.10.1046/j.1365-2265.2002.01654.x12390330
  11. 11. KAMATH PS., KIM WR. The model for end-stage liver disease (MELD). Hepatology 2007, 45(3):797-805.10.1002/hep.2156317326206
  12. 12. CHOLONGITAS E., PAPATHEODORIDIS GV., VANGELI M., TERRENI N., PATCH D., BURROUGHS AK. Systematic review: the model for end-stage liver disease - should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Alimentary Pharmacology & Therapeutics 2005; 22(11-12):1079-89.10.1111/j.1365-2036.2005.02691.x16305721
  13. 13. HÄUSER W., HOLTMANN G., GRANDT D. Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenter Hepatol. 2004; 2(2):157-63.10.1016/S1542-3565(03)00315-X
  14. 14. GUTTELING JJ., DE MAN RA., VAN DER PLAS SM., SCHALM SW., BUSSCHBACH JJW, DARLINGTON ASE. Determinants of quality of life in chronic liver patients. Aliment Pharmacol Therap 2006; 23(11):1629-35.10.1111/j.1365-2036.2006.02934.x16696813
  15. 15. AFENDY A., KALLMAN JB., STEPANOVA M., YOUNOSZAI Z., AQUINO RD., BIANCHI G., et al. Predictors of healthrelated quality of life in patients with chronic liver disease. Aliment Pharmacol Therap 2009; 30(5):469-76.10.1111/j.1365-2036.2009.04061.x19508612
  16. 16. PARKASH O., IQBAL R., JAFRI F., AZAM I., JAFRI W. Frequency of poor quality of life and predictors of health related quality of life in cirrhosis at a tertiary care hospital Pakistan. BMC Research Notes 2012; 5: 446.10.1186/1756-0500-5-446354215022905795
  17. 17. CHE YH., YOU J., CHOUNGSUVIVATWONG V., LI L., SRICPLUNG H., YAN YZ., et al. Dynamics and Liver Disease Specific Aspects of Quality of Life Among Patients with Chronic Liver Disease in Yunnan, China. Asian Pac J Cancer Prev 2014; 15(12): 4765-71.10.7314/APJCP.2014.15.12.4765
  18. 18. CHANG S-C., YANG S-S., CHANG C-C., LIN C-C., CHUNG Y-C., LI T-C. Assessment of health-related quality of life in antiviral-treated Taiwanese chronic hepatitis C patients using SF-36 and CLDQ. Health Qual Life Outcomes 2014; 12:97.10.1186/1477-7525-12-97407317824941994
  19. 19. THIELE M., ASKGAARD G., TIMM HB., HAMBERG O., GLUUD LL. Predictors of Health-Related Quality of Life in Outpatients with Cirrhosis: Results from a Prospective Cohort. Hepatitis Res Treat 2013; 2013.10.1155/2013/479639389606924490061
  20. 20. BONDINI S., KALLMAN J., DAN A., YOUNOSZAI Z., RAMSEY L., NADER F., et al. Health-related quality of life in patients with chronic hepatitis B. Liver Int 2007; 27(8):1119-25.10.1111/j.1478-3231.2007.01558.x17845541
  21. 21. YOUNOSSI ZM., BOPARAI N., PRICE LL., KIWI ML., MCCORMICK M., GUYATT G.Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol 2001; 96(7):2199-205.10.1111/j.1572-0241.2001.03956.x11467653
  22. 22. SVIRTLIH N., PAVIC S., TERZIC D., DELIĆ D., SIMONOVIC J., GVOZDENOVIC E. Reduced quality of life in patients with chronic viral liver disease as assessed by SF12 questionnaire. J Gastrointestin Liver Dis 2008; 17(4):405-9.
  23. 23. DAN AA., KALLMAN JB., WHEELER A., YOUNOSZAI Z., COLLANTES R., BONDINI S., et al. Health-related quality of life in patients with non-alcoholic fatty liver disease. Alimen Pharmacol Therap 2007; 26(6):815-20.10.1111/j.1365-2036.2007.03426.x17767465
  24. 24. PAVIC S., DELIC D., SIMONOVIC J., SVIRTLIH N. Quality of life in patients with chronic hepatitis C. Srp Arh Celok Lek 2011; 139(3-4):165-9.10.2298/SARH1104165P
  25. 25. MARTIN LM., DAN AA., YOUNOSSI Z. Measurement of health-related quality of life in patients with chronic liver disease. Liver Transplantation 2006; 12(1):22-3.10.1002/lt.2057516382455
  26. 26. KALAITZAKIS E., JOSEFSSON A., BJÖRNSSON E. Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study. BMC Gastroenterol 2008; 8(1):46.10.1186/1471-230X-8-46257520018922174
  27. 27. GOTARDO DRM., STRAUSS E., TEIXEIRA M-CD., MACHADO MCC.Liver transplantation and quality of life: relevance of a specific liver disease questionnaire. Liver Int 2008; 28(1):99-106.
DOI: https://doi.org/10.1515/rjim-2017-0014 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 129 - 137
Submitted on: Jan 16, 2017
Published on: Aug 19, 2017
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Milica Obradovic, Zoran Gluvic, Nina Petrovic, Milan Obradovic, Ratko Tomasevic, Predrag Dugalic, Esma R. Isenovic, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.